Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Important steps towards the development of a human vaccine against malaria

31.10.2008
Every day 2000 children die from malaria in Africa alone. The infection is transmitted from human to human by biting mosquitoes and remains one of the world’s most devastating diseases. Despite many years of effort a vaccine is still not available but is urgently needed, if we are to make an impact on this enormous problem.

Continual exposure can generate protection against malaria and can be acquired through an exposure to a high number of infectious mosquito bites. Parasites that are injected by a mosquito first migrate to the liver where they mature and then are released into the blood circulation and it is only here that they cause disease and fatal complications.

A very promising method for vaccination is to sufficiently weaken parasites such that they invade liver cells but then are not able to develop any further. It is, however, required that these attenuated parasites are still able to stimulate a good immune response in the liver. This can be achieved by irradiating the parasites or by genetically inactivating individual parasite genes that are active during the parasites growth in the liver. Researchers from Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands and LUMC, Leiden, the Netherlands, have now characterized a large number of parasite proteins (‘proteome’) that are present only during liver stage development and therefore are potential targets for inactivation.

The research groups had previously shown that protection in mice can be achieved by vaccinating mice with a rodent malaria which had one of these liver stage genes removed, specifically p36p. Moreover, the protection was long lasting and virtually complete. Now, these same researchers from Nijmegen and Leiden have succeeded in making the first critical transition from the rodent system to humans by inactivating the equivalent gene (p52) in the most important human malaria parasite, P. falciparum. Similar to the results with the rodent parasite, these human parasites are unable to develop in liver cells. This is the first time that genetic modification of a human parasite results in its growth arrest in a liver cell, opening up exciting possibilities for its use as a human vaccine.

These studies form part of a collaborative project with the American company Sanaria (www.sanaria.com), whose sole purpose is develop a whole organism malaria parasite vaccine for use in humans, and is funded by TI-Pharma. These studies show how results obtained in rodent models of malaria can be pipelined to form the basis for clinical development of anti-malaria vaccines in humans.

prof.dr. Robert Sauerwein | alfa
Further information:
http://www.umcn.nl

More articles from Life Sciences:

nachricht Atomic Design by Water
23.02.2018 | Max-Planck-Institut für Eisenforschung GmbH

nachricht Stiffness matters
22.02.2018 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Developing reliable quantum computers

International research team makes important step on the path to solving certification problems

Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Stiffness matters

22.02.2018 | Life Sciences

Magnetic field traces gas and dust swirling around supermassive black hole

22.02.2018 | Physics and Astronomy

First evidence of surprising ocean warming around Galápagos corals

22.02.2018 | Earth Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>